BCL2 and cancer: These molecules have been shown to reduce off‐target effects in biological experiments; ligand 3ao and 3ap could selectively downregulate the expression of c‐MYC and BCL2 genes, respectively via stabilization of promoter quadruplexes and eventually lead to apoptosis in cancer cells.